SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-23-014016
Filing Date
2023-11-09
Accepted
2023-11-09 16:09:02
Documents
44
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q drma_10q.htm   iXBRL 10-Q 670657
2 CERTIFICATION drma_ex311.htm EX-31.1 8989
3 CERTIFICATION drma_ex312.htm EX-31.2 8959
4 CERTIFICATION drma_ex321.htm EX-32.1 5321
  Complete submission text file 0001654954-23-014016.txt   3173591

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA drma-20230930.xsd EX-101.SCH 33114
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE drma-20230930_lab.xml EX-101.LAB 181207
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drma-20230930_cal.xml EX-101.CAL 23111
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drma-20230930_pre.xml EX-101.PRE 155139
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drma-20230930_def.xml EX-101.DEF 99251
38 EXTRACTED XBRL INSTANCE DOCUMENT drma_10q_htm.xml XML 503936
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40739 | Film No.: 231392422
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences